Harsányi, László
Kincses, Zsolt
Zehetner, Joerg
Altorjay, Áron
Funding for this research was provided by:
Implantica
Article History
Received: 6 May 2024
Accepted: 18 July 2024
First Online: 13 August 2024
Declarations
:
: Authors László Harsányi, Zsolt Kincses and Áron Altorjay declare that they have no competing interests. Joerg Zehetner has received honoraria from Implantica and Johnson & Johnson and grants/contracts from Implantica and Johnson & Johnson, not in relation to the present manuscript.
: <i>Ethics Committee: Hungary</i>---The Medical Research Council (MRC), Scientific and Research Ethics Committee (SREC, An independent Central Ethics Committee (CEC) responsible for the independent review and approval for all medical device trials in Hungary. Trial approval reference number: 048734/2016/OTIG, issued by the Hungary Regulatory Authority the National Institute of Pharmacy and Nutrition), Alkotmány u. 25, H-1054 Budapest, Hungary. <i>Ethics Committee: Serbia</i>---Ethics Committee of Serbia (EOS), Vojvode Stepe 458, 110000 Belgrade, Serbia.
: Informed written consent was obtained from all individual participants included in the study.
: All subjects have signed an Informed Consent Form in relation to their participation in the CE-mark clinical investigation RXI 001 of RefluxStop™, which provides consent for the publication of anonymized data.